title: Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha.
abstract: Toll-like receptors (TLRs) are pattern-recognition receptors that recognize microbial ligands and subsequently trigger intracellular signaling pathways involving transcription factors such as NFκB and MAPKs such as p38. TLR signaling can regulate both transcriptional and post-transcriptional events leading to altered gene expression and thus appropriate immune responses. The interleukin-1 receptor-associated kinase (IRAK) family comprises four kinases that regulate TLR signaling. However, the role of IRAK-2 has remained unclear, especially in human cells. Recent studies using cells from in-bred Irak2(-/-) mice showed that murine IRAK-2 was not required for early TLR signaling events but had a role in delayed NFκB activation and in cytokine production. IRAK-2 in mice has four splice variants, two of which are inhibitory, whereas human IRAK-2 has no splice variants. Thus IRAK-2 in mice and humans may function differently, and therefore we analyzed the role of IRAK-2 in TLR responses in primary human cells. siRNA knockdown of IRAK-2 expression in human peripheral blood mononuclear cells showed a role for human IRAK-2 in both TLR4- and TLR8-mediated early NFκB and p38 MAPK activation and in induction of TNF mRNA. These data conflict with findings from the in-bred Irak2(-/-) mice but concur with what has been seen in wild-derived mice for TLR2. Moreover, human IRAK-2 was required for regulating MyD88-dependent TNFα mRNA stability via the TNF 3'UTR. Collectively, these data demonstrate for the first time an essential role for IRAK-2 in primary human cells for both transcriptional and post-transcriptional TLR responses.
authors: School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
authors: Sinead M
authors: SM
authors: Flannery
authors: Sinead E
authors: SE
authors: Keating
authors: Joanna
authors: J
authors: Szymak
authors: Andrew G
authors: AG
authors: Bowie
references: Nat Immunol. 2008 Jun;9(6):684-91
references: 18438411
references: J Exp Med. 2005 Mar 21;201(6):915-23
references: 15767370
references: J Immunol. 2011 Mar 1;186(5):3006-14
references: 21270393
references: Nat Rev Immunol. 2006 Jul;6(7):532-40
references: 16799472
references: J Immunol. 2005 Feb 1;174(3):1259-68
references: 15661881
references: Nature. 2010 Jun 17;465(7300):885-90
references: 20485341
references: Science. 1996 Feb 23;271(5252):1128-31
references: 8599092
references: J Immunol. 1999 Jul 15;163(2):978-84
references: 10395695
references: J Biol Chem. 2009 Apr 17;284(16):10367-75
references: 19224918
references: Cell. 2010 Mar 19;140(6):805-20
references: 20303872
references: Biochem Pharmacol. 2010 Dec 15;80(12):1981-91
references: 20599782
references: Mol Cell Biol. 1995 Apr;15(4):2219-30
references: 7891716
references: J Biol Chem. 2008 Jun 6;283(23):15689-93
references: 18411265
references: J Biol Chem. 2007 Feb 9;282(6):4102-12
references: 17135271
references: J Interferon Cytokine Res. 2011 May;31(5):415-22
references: 21291324
references: J Exp Med. 2009 Jul 6;206(7):1615-31
references: 19564352
references: Nature. 2001 Sep 6;413(6851):78-83
references: 11544529
references: Biochem Biophys Res Commun. 2002 Sep 13;297(1):52-8
references: 12220507
references: Nat Immunol. 2006 Apr;7(4):375-81
references: 16491077
references: J Exp Med. 2007 May 14;204(5):1025-36
references: 17470642
references: J Immunol. 2004 Aug 15;173(4):2755-61
references: 15294994
references: FEBS Lett. 2000 Oct 13;483(1):57-61
references: 11033356
references: J Exp Med. 2003 Feb 3;197(3):343-51
references: 12566418
references: Nat Immunol. 2003 Nov;4(11):1144-50
references: 14556004
references: Cell. 2006 Feb 24;124(4):783-801
references: 16497588
references: Mol Cell Biol. 2004 Jun;24(11):4835-47
references: 15143177
references: J Biol Chem. 2004 Jun 25;279(26):27699-708
references: 15082713
references: J Biol Chem. 2005 Sep 2;280(35):30838-44
references: 15998638
references: Cell. 1981 Oct;26(2 Pt 2):191-203
references: 7332928
references: J Immunol. 2009 Jun 1;182(11):6824-33
references: 19454678
references: Nat Immunol. 2003 Feb;4(2):161-7
references: 12539043
references: Nature. 2002 Apr 18;416(6882):750-6
references: 11923871
references: Mol Cell Biol. 2008 Dec;28(24):7296-308
references: 18824541
references: Science. 2003 Mar 28;299(5615):2076-9
references: 12637671
references: J Biol Chem. 2007 Nov 16;282(46):33435-33443
references: 17878161
references: PLoS One. 2008;3(12):e4064
references: 19112497
references: J Immunol. 2000 Apr 15;164(8):4301-6
references: 10754329
references: Nat Immunol. 2008 Apr;9(4):353-9
references: 18349815
references: J Biol Chem. 2001 Mar 2;276(9):6666-74
references: 11076936
references: J Exp Med. 1998 Jun 15;187(12):2073-9
references: 9625767
references: Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72
references: 11960013
references: Curr Top Microbiol Immunol. 2002;270:155-67
references: 12467250
references: J Exp Med. 2007 Oct 1;204(10):2407-22
references: 17893200